7th Floor, Building 2B 29 Shang Di East Road HaiDian District Beijing, P.R.China 100085AbMax provides monoclonal antibody development services and services for recombinant protein expression, gene cloning and synthesis, antibody conjugation and antibody imaging.

Room 206 No. 28 west, Shangdi Sixth Street, Haidian District Beijing, 100085 ChinaCustom murine and rat monoclonal antibody services; custom rabbit and rat polyclonal antibody services; antigen preparation, antibody purification and characterization. High quality with competitive prices.

Room C126-C130, 16 Zicheng JiaYuan, Zicheng Pioneer Park Beijing, HaiDian ChinaAidlab Biotechnologies offers DNA/RNA extraction, western blotting, PCR, protein expression.purification, and oligo synthesis services.

N 2nd Ave SW Unit 3101, L31, Yintai Office Tower C Chaoyang, Beijing, 100022 ChinaAnalysis Group has a global footprint of integrated health care research capabilities. Across offices in North America, Europe, and Asia, we leverage our distinguished network of advanced-degree consultants, affiliated experts, and key opinion leaders to carry out an extensive range of work that includes real-world data (RWD) and real-world evidence (RWE) studies, post-marketing safety and effectiveness studies, indirect treatment comparisons, patient-reported outcomes (PROs), systematic literature reviews (SLRs) and meta-analysis, and AI-aided data solutions. Our clients benefit from our highly qualified teams across the world, which have substantial knowledge of local data, laws, and regulations but are also able to leverage our entire firm’s depth of expertise and integrate it seamlessly with local resources. We have supported the approval, launch, and market acceptance of numerous life sciences innovations in the US, EU and individual European countries. We have also provided expert input and testimony to regulatory and health technology assessment (HTA) bodies.

Room 2202,2th Floor,No.123 Zhongguancun North Street,Haidian District Beijing, 100084 ChinaAnalytical Biosciences is a single-cell genomics company driven to accelerate the development of novel therapeutics through single-cell RNA sequencing. Our company was founded to create and harness the human disease precision atlas through cutting-edge single-cell genomics and bioinformatics. Fostering ecosystem building and open innovation, we offer our expertise and laboratory services to advance your discovery research. Our services portfolio grows our atlas and provides world-class solutions to speed the drug discovery process, improving clinical success, lowering overall costs, enabling better decisions, and saving lives. Our 10x Genomics credentials include the following: • Compatible Partner Program (CPP) Certification for Data Analysis • Visium Enablement Program (VEP) Qualification for Visium Spatial Solutions • Certified Service Provider (CSP) for Single Cell Immune Profiling • Certified Service Provider (CSP) for Spatial Gene Expression

Room 1515,5th Floor,No.123 Zhongguancun North Street,Haidian District Beijing, 100084 ChinaAnalytical Biosciences is a single-cell genomics company driven to accelerate the development of novel therapeutics through single-cell RNA sequencing. Our company was founded to create and harness the human disease precision atlas through cutting-edge single-cell genomics and bioinformatics. Fostering ecosystem building and open innovation, we offer our expertise and laboratory services to advance your discovery research. Our services portfolio grows our atlas and provides world-class solutions to speed the drug discovery process, improving clinical success, lowering overall costs, enabling better decisions, and saving lives. Our 10x Genomics credentials include the following: • Compatible Partner Program (CPP) Certification for Data Analysis • Visium Enablement Program (VEP) Qualification for Visium Spatial Solutions • Certified Service Provider (CSP) for Single Cell Immune Profiling • Certified Service Provider (CSP) for Spatial Gene Expression

Beijing Economic and Technological Development Area (BDA), the 3rd hospital day South China Street, Building 5 Daxing, Beijing 100176 ChinaAn Biqi Biological Technology specializes in antibody preparation, antibody development, and stable cell line construction.

Beijing, Beijing ChinaApexmol Technology is a company specialized in providing innovative chemical intermediates and chemistry services to the chemical R&D all over the world.

No. 9-1 Madian East Road Haidian District Beijing ChinaAQSIQ laboratory boasts the ability to issue (GB-CHINA) Laboratory certificates to companies and individuals exporting food and feed products to the Republic of CHINA. AQSIQ laboratory in 2002 became the first official laboratory to be approved by the China Food & Drug Administration to test for pesticide residues and Food Microbiology, this scope was broadened in 2009 to include testing and certification in the fields of nutrition, food supplements, and Food Chemistry Analysis. The benefit of AQSIQ laboratory ‘s scope of accreditation are more security: Exporters can now rest assured that their cargo will be accepted at china ports of entry because AQSIQ standards have been met, China consumers will have peace of mind knowing that their food products are safe and compliant with china food labeling standards, AQSIQ laboratory issued of test report with chinese version will be recognized in every port of China CIQ.

No. 9-1 Madian East Road Beijing, Haidan District ChinaAQSIQ laboratory boasts the ability to issue (GB-CHINA) Laboratory certificates to companies and individuals exporting food and feed products to the Republic of CHINA. AQSIQ laboratory in 2002 became the first official laboratory to be approved by the China Food & Drug Administration to test for pesticide residues and Food Microbiology, this scope was broadened in 2009 to include testing and certification in the fields of nutrition, food supplements, and Food Chemistry Analysis. The benefit of AQSIQ laboratory ‘s scope of accreditation are more security: Exporters can now rest assured that their cargo will be accepted at china ports of entry because AQSIQ standards have been met, China consumers will have peace of mind knowing that their food products are safe and compliant with china food labeling standards, AQSIQ laboratory issued of test report with chinese version will be recognized in every port of China CIQ.

No. 5 Shangdi Kaituo Road, Suite A306 Zhongguancun Biomedical Garden Haidian District, Beijing 100085, ChinaAutekBio offers protein expression services, cell line development services, process development services and pre-clincal scale contract manufacturing.

3rd Floor Building A, Xinghuo Road, Fengtai High Tech Park, Fengtai District, Beijing China 100070Beijing Ascend Tech offers DMPK services for synthetic and biotechnology products in drug discovery, preclinical, or clinical development.

Beijing, ChinaBeijing BRD Pharma. Science and Tech. offers drug development, clinical studies, and consulting.

No.33, Life Science Park Road, Beijing 102206, ChinaBeijing C&N International Sci-Tech offers preclinical evaluation, pharmacology, toxicity tests, teratogenesis, hemolysis, and drug screening.

602 Room, Power Creative A, NO 1, Shangdi East Road, Haidian District Beijing, ChinaBeijing Cowin Biotech offers molecular biology, protein expression, custom antibody, and immunoassay services in addition to supplying research reagents and products.

Beijing, ChinaBeijing Difuyuan Medicine Technology provides registration of medical devices, drugs, and APIs.

Shuangqiao Donglu Chaoyang District, Beijing, 100121Beijing Garlin Pharmaceutical offers APIs, cardiovascular drugs, and anticancer drugs.

Beijing, Beijing ChinaBeijing Garlin Pharmaceutical offers APIs, cardiovascular drugs, and anticancer drugs.

China Beijing Bioengineering and Pharmaceutical Industrial Park, Beijing, ChinaBeijing Honghui Meditech offers lead generation, medicinal chemistry, chemical synthesis, process development, clinical research, and scale-up.

BUILDING 14, NO. 79 SHUANGYING XI ROAD CHANGPING DISTRICT Beijing, State/Province, 102200 ChinaFounded in September 2020, Beijing InnoModels Biotechnologies specializes in providing preclinical pharmacology, translational research, and IIT CRO services. Our comprehensive offerings include both in vivo and in vitro experiments focused on oncology, immuno-oncology, autoimmune disease, and metabolic disease models. These services encompass molecular and cell biology, humanized immune system mouse models, an extensive collection of PDX models (18,000), PDC, organiod, CDX, syngeneic tumor models, PK/PD studies, non-GLP toxicology, IND filing studies, and more.

Beijing Tiantan Xili 4 Dongcheng District, 100050 ChinaIn order to build a first-rate modern dental hospital in China, every leadership has been holding highly the policy of “invigorating hospital through science and education” and attaching great importance to teaching and research activities. Human, material and capital resources have been devoted to fast development of teaching and research, and as a result, the overall level has been improved. 　　All medical workers actively integrate oral clinical medicine with scientific research, and the research area is ever expanding and deepening since the school’s establishment in 1980’s. The current pattern is for clinical and basic research to promote each other and comprehensive research and specialized research to complement each other. After 20 years of development, we have formed a platform for oral medicine research, and our Institute of Dental Research has become an important site for oral medicine and graduate student training. Our Laboratory for Gene Therapy and Molecularbiology, Laboratory of Oral Microbiology and Laboratory for Caries and Experimental Pathology are conducting many a national research projects, such as 863 National Key Project, National Funding Project for Outstanding Young Scientists, National Funding Project for Natural Science. Meanwhile, it also cooperates with National Institutes of Health of the U.S.A (NIH) and universities and research institutes from France, Japan and some other countries. 　　Since 1990, this hospital has been awarded more than 50 awards of different kinds and levels (national, municipal and institutional). Its annual publications are more than 90, appearing in all kinds of academic periodicals and magazines. The hospital ranks high in orthodontics, prosthodontics, oral medicine, etc. With the development of the hospital, its investment in research is on the increase year by year, and as a result, the research conditions have been improved. Ever since 2000, the hospital has conducted 62 research projects of the nation, the Ministry of Public Health, Beijing municipality, Beijing Public Health Bureau and Capital Medical University.

No. 11, Huatong Road Science and Technology Park Changping District Beijing, 102200 ChinaBeijing Agricultural Science and Technology Co., Ltd. precision farming world (securities referred to: precision farming world, stock code: 430 108) is a company registered in the Zhongguancun Science Park, the new board in the Shenzhen Stock Exchange listing of professionals committed to the sustainable development of agricultural technologies, services and products The national high-tech enterprises. The company is China's agricultural services enterprises hundred National Agrochemical service center, the capital boost food security units outstanding, has won China organic product certification, ISO9001-2008 international quality management system certification, the national high-tech enterprise certification, patent pilot Units, the EU ECOCERT organic certification, and access to national import and export inspection and quarantine designated testing agency that the "green enterprises". The company is the number of provinces in government procurement sentinel providers, perennial products exported to overseas markets. The company is strong in scientific research, a number of professors and experts in soil and fertilizer science, microbiology, chemistry, machinery and other research, the company's management team consists of more than engage in financial and business management experts, business college education staff of the total number of employees 50 % the above. Precision farming world has strong fermentation engineering, agricultural microbial strains, new eco-fertilizer , microbial fertilizer, agricultural and environmental machinery and equipment research and production capacity, large-scale production, including Streptomyces, Bacillus, thermophilic bacteria, Metarhizium, bassiana, Trichoderma species and more than ten kinds of high-performance water-soluble drip irrigation fertilizer, trace element fertilizer, fertilizer, microbial agents, (bio) organic fertilizer, compound microbial fertilizer, slow release fertilizer, environmental treatment like new eco-fertilizer products and advanced agricultural and environmental machinery and equipment.

West Ring Road, Beijing Economic Development Zone No. 18, A-403, Beijing, China 100176Beijing Kaizheng Biotech Development offers human blood substitute and pharmacology.

!406 Biotechnology Business Incubator of Haidian Science Park, No 5 Shandi Kaituo Road, Haidian District, Beijing, ChinaBeijing Northland Bio offers protein production, gene services, electrophoresis, and freezing.

Beijing Pharma and Biotech Center,151 Ma Lian Wa North Road, Haidian Dist Beijing, 100193 ChinaBeijing Pharma and Biotech Center offers genomics, drug screening, pilot plant trials, genetic therapeutics, and protein engineering.

B-8,Beijing Airport Industrial Zone Beijing 101318 ChinaBeijing Protein Innovation Co., Ltd. (北京华大蛋白质研发中心有限公司), established in 2003, holds the qualification of a Beijing Municipal R&D Institution and is recognized as a "Specialized, Refined, Unique, and Innovative" (专精特新) enterprise. The company specializes in protein and antibody technology development, product innovation, and related technical services, building upon its core expertise in mass spectrometry and immunology technologies. The company has established comprehensive experimental and production systems, including:An R&D Department ，A Recombinant Protein Platform，An Antibody Development Platform，A Protein Mass Spectrometry Platform and A Drug Metabolism Testing Laboratory. Its infrastructure features including: A 250-square-meter SPF-grade animal facility,,Clean cell culture rooms, A 500-square-meter mass spectrometry testing and the Drug Metabolism Testing Laboratory accredited to ISO/IEC 17025 standards.

北京市顺义区临空经济核心区裕华路28号8号楼4层8401室 Building 8,Beijing Airprot Industrial Zone Shunyi District, Beijing, Beijing, 101318 ChinaBeijing Protein Innovation Co., Ltd. (北京华大蛋白质研发中心有限公司), established in 2003, holds the qualification of a Beijing Municipal R&D Institution and is recognized as a "Specialized, Refined, Unique, and Innovative" (专精特新) enterprise. The company specializes in protein and antibody technology development, product innovation, and related technical services, building upon its core expertise in mass spectrometry and immunology technologies. The company has established comprehensive experimental and production systems, including:An R&D Department ，A Recombinant Protein Platform，An Antibody Development Platform，A Protein Mass Spectrometry Platform and A Drug Metabolism Testing Laboratory. Its infrastructure features including: A 250-square-meter SPF-grade animal facility,,Clean cell culture rooms, A 500-square-meter mass spectrometry testing and the Drug Metabolism Testing Laboratory accredited to ISO/IEC 17025 standards.

Beijing, ChinaBeijing Huada Protein Research and Development Center Co., Ltd. was established in 2003. After years of development, the company has formed a technical system mainly consisting of proteomics platform, antibody platform, drug research and development platform, drug metabolism detection platform, and fine recombinant protein production platform. Huada Protein's current business mainly covers four parts: technology services, products, contract research and development, and drug analysis. Among them, technology services mainly include gene synthesis and cloning, protein expression and purification, antibody preparation and identification, metabolomics, proteomics, and biochips. Products mainly include monoclonal antibodies, recombinant proteins, protein chips, metabolome targeted analysis kit and other categories. Contract research and development mainly includes disease biomarker screening, detection product development, and high-quality diagnostic raw material development. Drug analysis mainly includes animal pharmacokinetic analysis, gene toxicity impurity detection, etc. The company is located in the core area of Beijing's aviation economy, adjacent to the Capital International Airport, Airport Expressway, Jingcheng Expressway, Jingshen Expressway, and Metro Line 15, with convenient international and domestic transportation. The customer base covers major research institutes, schools, and enterprises and institutions. In 2017, Saisheng Pharmaceutical invested in Huada Protein, injecting new vitality into the company's transformation and upgrading.

Beijing, ChinaBeijing Randa Consulting offers clinical trials, blood tests, immunologic tests, and pathology.

Room 1103, Jinyu Building, 100 Xisanhuan Beilu Beijing, 100037 ChinaBeijing SL Pharmaceutical (SL Pharm) offers API, intermediates, and generics.

No.26，DongBeiWangNan Road Beijing, HaiDian ChinaBeijing Sunbiotech offers DNA sequencing, DNA synthesis, and molecular biology services.

Beijing, Beijing ChinaBeijing Union-Genius Pharmaceutical Technology offers safety evaluations, clinical trials, toxicology, pharmacology, and drug registration.

Rm B303, Guantong Building No.44 Huayuan North Road Haidian District, Beijing, 100191 ChinaUniQuantus Biotech Co.,Ltd with the headquarters in Beijing,provides cutting-edge imaging technology and advanced solutions for studying complex biological samples and research models, including in vivo, tissue and cell imaging and analysis. Our solutions enable researchers to identify disease pathways, develop accurate diagnostics, evaluate drug candidates, and discover effective therapies. Our team has the ability and willingness to support customers with quality products and reliable services. which has set UniQuantus apart.

2nd floor, Sangpu Building #10 Beiyuan Road Chaoyang District, Beijing, 100012 ChinaVitalstar supports customers’ R&D activity from disease model mouse to preclinical studies. We are mainly provide 4 kinds of products or services, including custom production of genetically modified mice, humanized mouse (disease) model, cell products, and conventional manipulation services of mice or mouse embryos. We are one of the leading providers of custom-made mouse models, including transgenic, knockout, knocking and humanized mouse model. We offer one-stop solutions to our customer needs, ranging from vector construction, ES cell manipulation, embryo microinjection and transfer, embryo staining, to genotyping. Our services are fully customizable and 100% flexible, so our customers can have the option of outsourcing to us at any stage of the project. We build vectors for knockout, conditional knockout, knocking, and knockdown mouse models. We also build vectors for transgene expression using a variety of systems such as Talen, lentivirus, retrovirus, adenovirus, ÞiggyBac, and regular plasmids. Vitalstar helps secure your investment by providing you with the most reliable mouse transgenesis services currently on the market.

Beijing, 100012 ChinaVitalstar supports customers’ R&D activity from disease model mouse to preclinical studies. We are mainly provide 4 kinds of products or services, including custom production of genetically modified mice, humanized mouse (disease) model, cell products, and conventional manipulation services of mice or mouse embryos. We are one of the leading providers of custom-made mouse models, including transgenic, knockout, knocking and humanized mouse model. We offer one-stop solutions to our customer needs, ranging from vector construction, ES cell manipulation, embryo microinjection and transfer, embryo staining, to genotyping. Our services are fully customizable and 100% flexible, so our customers can have the option of outsourcing to us at any stage of the project. We build vectors for knockout, conditional knockout, knocking, and knockdown mouse models. We also build vectors for transgene expression using a variety of systems such as Talen, lentivirus, retrovirus, adenovirus, ÞiggyBac, and regular plasmids. Vitalstar helps secure your investment by providing you with the most reliable mouse transgenesis services currently on the market.

Building 9, Courtyard 10, Linhe Street ShunYi District, Beijing, 101300 ChinaAn Integrated Contract Chemistry Service Organisation Since 2010, Bellen Chemistry has been providing chemistry CRO/CDMO services as an integrated Contract Chemistry Service Organization. With years of accumulated technical advantages and experience in chemical synthesis of small molecule compounds, Bellen has built a one-stop-shop chemistry service platform, supporting big pharmas, biotech innovators and new drug development institutions for their research programs from discovery to commercial stage through comprehensive chemistry solutions. Our R&D, production, sales and operation team are based globally and at present, Bellen has nearly 1,000 employees worldwide, of which our technical team accounts for around 50%. Bellen is committed to continuing investing in innovation and state-of-the-art facilities to enable a one-stop-shop chemistry service platform, adding value to your project from library synthesis to API GMP manufactory. Our Key Services & Capabilities: - Key intermediates & RSMs (non-GMP & GMP) - cGMP APIs - Flow chemistry & Biocatalysis - Process development & optimisation - Process safety assessment - Early phase scale up - Late phase API & intermediates manufacturing - Solid Phase & Recrystallisation platforms (New for 2023) Watch our introductory video here: https://www.youtube.com/watch?v=6EoahD-c6WI

No.1, Caida 3rd Street, MaoHua Garden - ShunYi District Beijing, 101300 ChinaAn Integrated Contract Chemistry Service Organisation Since 2010, Bellen Chemistry has been providing chemistry CRO/CDMO services as an integrated Contract Chemistry Service Organization. With years of accumulated technical advantages and experience in chemical synthesis of small molecule compounds, Bellen has built a one-stop-shop chemistry service platform, supporting big pharmas, biotech innovators and new drug development institutions for their research programs from discovery to commercial stage through comprehensive chemistry solutions. Our R&D, production, sales and operation team are based globally and at present, Bellen has nearly 1,000 employees worldwide, of which our technical team accounts for around 50%. Bellen is committed to continuing investing in innovation and state-of-the-art facilities to enable a one-stop-shop chemistry service platform, adding value to your project from library synthesis to API GMP manufactory. Our Key Services & Capabilities: - Key intermediates & RSMs (non-GMP & GMP) - cGMP APIs - Flow chemistry & Biocatalysis - Process development & optimisation - Process safety assessment - Early phase scale up - Late phase API & intermediates manufacturing - Solid Phase & Recrystallisation platforms (New for 2023) Watch our introductory video here: https://www.youtube.com/watch?v=6EoahD-c6WI

No. 12, Baoshen South Street Daxing Bio-Medicine Industry Park Daxing, Beijing, 102609 ChinaBiocytogen provides comprehensive, one-stop solutions for next-generation drug development, supporting the global biomedical community from target identification to IND application. Leveraging proprietary gene-editing technology and the innovative RenMice® platforms, Biocytogen offers fully human antibody discovery, featuring a library of over 400,000 sequences targeting nearly 1,000 antigens for global partnerships. Our technical teams also deliver an extensive portfolio of products and services, including drug-targeted humanized models, comprehensive preclinical pharmacology services, and custom gene-editing solutions. Biocytogen collaborates with all top 10 and 70% of the top 50 pharmaceutical companies, as well as numerous biotech start-ups worldwide, driving innovation in drug discovery and development.

Building E, No. 29 Life Science Park Road Changping District, Beijing, 102206 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

Changping District No. 29 Life Science Park Road Beijing, Beijing, 102206 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

5th Floor, JD Technology Tower No. 76 Zhichun Road, Haidian District Beijing, Beijing, 100000 ChinaBioMap is a global pioneer in AI foundation models for life sciences. We are charting the map of life sciences, replacing fragmented, trial-and-error experimentation with systematic, computational, and predictable discovery powered by life science AI foundation models. Our mission is to converge massive biological data with large-scale model technologies, building the essential infrastructure for a new era where discovery is faster, deeper, and far more reliable. As a global pioneer and leader in foundation model-driven R&D, we created BioMap OS—a world-leading life science discovery AI system. Validated across multiple programs with early commercial traction, BioMap OS is powered by xTrimo, our proprietary foundation model family with over 268 billion parameters. xTrimo continuously strengthens BioMap OS in performance, breadth, and applicability, forming its intelligent backbone. Through BioMap OS, we deliver a unified platform that models and predicts complex biological mechanisms, explores uncharted design spaces, boosts discovery efficiency and success rates, and unlocks breakthroughs beyond the reach of traditional methods—systematizing life science innovation at global scale.

12 Fuqian Street Shunyi District Beijing, 101300 ChinaBiomarker Technologies (BMKGENE) GmbH is an industry-leading international multi-omics sequencing service provider with laboratories in Europe, Asia and North America. We have over 14 years of experience in offering high-quality, customized sequencing and bioinformatics solutions to scientists in academic institutions, biotech companies as well as clinical research. Our European headquarters are located in Münster, Germany. Our services cover genomics, transcriptomics, epigenetics and microbiomics, as well as proteomics and metabolomics. We have platforms for long- and short-read sequencing, single-cell-omics, and spatial transcriptomics. Apart from delivering professional, cost-effective sequencing solutions with fast turnaround times, we are also able to offer long-term technical and bioinformatics support if needed.

12 Fuqian Street Shunyi District Beijing, 10130 ChinaBiomarker Technologies (BMKGENE) GmbH is an industry-leading international multi-omics sequencing service provider with laboratories in Europe, Asia and North America. We have over 14 years of experience in offering high-quality, customized sequencing and bioinformatics solutions to scientists in academic institutions, biotech companies as well as clinical research. Our European headquarters are located in Münster, Germany. Our services cover genomics, transcriptomics, epigenetics and microbiomics, as well as proteomics and metabolomics. We have platforms for long- and short-read sequencing, single-cell-omics, and spatial transcriptomics. Apart from delivering professional, cost-effective sequencing solutions with fast turnaround times, we are also able to offer long-term technical and bioinformatics support if needed.

A3 Yihai building 14,Qinghua east road 16, Haidian District Beijing, ChinaBroadPharma is specialized on developing and producing bulk drugs and pharmaceutical intermediates and providing contract -customized service.

CAMECA Beijing Office Western Section, 2nd Floor Jing Dong Fang Building (B10) Chaoyang District Beijing, 100015 China

18 Life Science Parkway Changping District Beijing 102206 ChinaCapitalBio offers SNP detection services, comparative genomic hybridization (CGH) services, expression profiling services, ChIP on Chip services and expression array construction services.

Beijing, ChinaCTL offers products and services for immune assays. These include a library of cryopreserved human PBMC with HLA-typed donors that have established T cell reactivity. We specialize in immune characterization through ELISPOT, providing ImmunoSpot analyzers, ImmunoSpot kits, hands-on wetlab training, consultation, and GLP contract research.

Bldg#16, Tsinghua Science Park Yuquan Wisdom Vale Minzhuang Rd #3 Beijing, Haidian District 100195 ChinaCentaurus BioPharma offers medicinal chemistry, library chemistry, custom synthesis, discovery biology, bioanalytical, DMPK, and pharmacology services.

No. 66, Changwa Zhongjie, Haidian District, Beijing, China Beijing, Beijing, 100089 ChinaChina Isotope And Radiation Corporation(CIRC) is a leading nuclear technology application enterprise in China that integrates research and development, production, sales, and services, CIRC is a pioneer in isotope and radiation technology in China and the largest supplier and service provider of diagnostic and therapeutic radioactive drugs in China. Our business covers seven business units: radiopharmaceutical, medical diagnostics, nuclear medical equipment, radioactive sources, irradiation applications, radionuclide manufacturing, such as C-14 Barium Carbonate, C-14 labeled compounds, C-14 custom synthesis, import and export trade. On July 6, 2018, CIRC was successfully listed on the Hong Kong Stock Exchange.

NO. 9, Dongdan san tiao, Dongcheng District, Beijing, P. R. China 100730The institute of Laboratory Animal Science (ILAS) is one of the 18 institutes of Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC). CAMS, established in 1956, is the country's largest multidisciplinary institution for biomedical research. PUMC, founded in 1917 by Rockefeller foundation, is the only key medical university in China that carries an eight-year curriculum. CAMS and PUMC are under the leadership by the same governing body overseeing all affairs of medical research, education and patient care. The ILAS, is a unique comprehensive institute for research, education, service and production of laboratory animals in China. Its mission is to build up ILAS as a world-class bases of comparative medical research and laboratory animal model development, which would support drug discovery, vaccine development, and researches on pathogenic mechanisms of several human diseases, such as cardiovascular disease, metabolic syndrome, Alzheimer disease, infectious diseases, etc.. On the basis of its research laboratories in Comparative Medical Center, Genetic Center, Pathogen Experimental Research Center and Laboratory Animal Resource Center, ILAS has developed a technology supporting system open to the researchers all over the country in the field of engineering animal models, laboratory animal pathology, imaging analysis, laboratory animal behavior analysis, infection disease animal models. The ILAS is certified by China National Accreditation Board for Laboratories, in which the GLP system of ILAS is certified by China SFDA. The ILAS is also one of the organizations in China accredited by AAALAC International. The institute is dedicating to the development of animal models for fateful diseases, and emerging infectious diseases, establishing systems for genetic engineering, embryo preservation, quality control, sharing laboratory animal resources, and professional training. The institute is ready to position itself as a strong support for life science research in China. The Chinese Association for Laboratory Animal Sciences (CALAS), and Chinese Laboratory Animal Standardization Committee (CLASC) are two affiliated societies of the institute. Two journals of ACTA Laboratorium Animalis Scientia Sinica and Chinese Journal of Comparative Medicine published by CALAS, are the national levels of scientific periodicals in China.

NO. 9, Dongdan san tiao Beijing, Dongcheng District, 100730 ChinaThe institute of Laboratory Animal Science (ILAS) is one of the 18 institutes of Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC). CAMS, established in 1956, is the country's largest multidisciplinary institution for biomedical research. PUMC, founded in 1917 by Rockefeller foundation, is the only key medical university in China that carries an eight-year curriculum. CAMS and PUMC are under the leadership by the same governing body overseeing all affairs of medical research, education and patient care. The ILAS, is a unique comprehensive institute for research, education, service and production of laboratory animals in China. Its mission is to build up ILAS as a world-class bases of comparative medical research and laboratory animal model development, which would support drug discovery, vaccine development, and researches on pathogenic mechanisms of several human diseases, such as cardiovascular disease, metabolic syndrome, Alzheimer disease, infectious diseases, etc.. On the basis of its research laboratories in Comparative Medical Center, Genetic Center, Pathogen Experimental Research Center and Laboratory Animal Resource Center, ILAS has developed a technology supporting system open to the researchers all over the country in the field of engineering animal models, laboratory animal pathology, imaging analysis, laboratory animal behavior analysis, infection disease animal models. The ILAS is certified by China National Accreditation Board for Laboratories, in which the GLP system of ILAS is certified by China SFDA. The ILAS is also one of the organizations in China accredited by AAALAC International. The institute is dedicating to the development of animal models for fateful diseases, and emerging infectious diseases, establishing systems for genetic engineering, embryo preservation, quality control, sharing laboratory animal resources, and professional training. The institute is ready to position itself as a strong support for life science research in China. The Chinese Association for Laboratory Animal Sciences (CALAS), and Chinese Laboratory Animal Standardization Committee (CLASC) are two affiliated societies of the institute. Two journals of ACTA Laboratorium Animalis Scientia Sinica and Chinese Journal of Comparative Medicine published by CALAS, are the national levels of scientific periodicals in China.

52 Sanlihe Rd., Beijing, China (100864)The Chinese Academy of Sciences is the linchpin of China’s drive to explore and harness high technology and the natural sciences for the benefit of China and the world. Comprising a comprehensive research and development network, a merit-based learned society and a system of higher education, CAS brings together scientists and engineers from China and around the world to address both theoretical and applied problems using world-class scientific and management approaches. Since its founding, CAS has fulfilled multiple roles — as a national team and a locomotive driving national technological innovation, a pioneer in supporting nationwide S&T development, a think tank delivering S&T advice and a community for training young S&T talent. Now, as it responds to a nationwide call to put innovation at the heart of China’s development, CAS has further defined its development strategy by emphasizing greater reliance on democratic management, openness and talent in the promotion of innovative research. With the adoption of its Innovation 2020 programme in 2011, the academy has committed to delivering breakthrough science and technology, higher caliber talent and superior scientific advice. As part of the programme, CAS has also requested that each of its institutes define its “strategic niche” — based on an overall analysis of the scientific progress and trends in their own fields both in China and abroad — in order to deploy resources more efficiently and innovate more collectively.

52 San Li He Lu Beijing, Beijing Shi ChinaThe Chinese Academy of Sciences is the linchpin of China’s drive to explore and harness high technology and the natural sciences for the benefit of China and the world. Comprising a comprehensive research and development network, a merit-based learned society and a system of higher education, CAS brings together scientists and engineers from China and around the world to address both theoretical and applied problems using world-class scientific and management approaches. Since its founding, CAS has fulfilled multiple roles — as a national team and a locomotive driving national technological innovation, a pioneer in supporting nationwide S&T development, a think tank delivering S&T advice and a community for training young S&T talent. Now, as it responds to a nationwide call to put innovation at the heart of China’s development, CAS has further defined its development strategy by emphasizing greater reliance on democratic management, openness and talent in the promotion of innovative research. With the adoption of its Innovation 2020 programme in 2011, the academy has committed to delivering breakthrough science and technology, higher caliber talent and superior scientific advice. As part of the programme, CAS has also requested that each of its institutes define its “strategic niche” — based on an overall analysis of the scientific progress and trends in their own fields both in China and abroad — in order to deploy resources more efficiently and innovate more collectively.

Level 13, Building A3 No.9 Chegongzhuang Avenue Beijing, 100044 ChinaFounded in 1954, Chongqing Normal University (hereafter as “CNU”) is a full-time comprehensive institution of higher education under the leadership of Chongqing Municipal Government of P. R. China. CNU covers an area of over 190 hectares (2800 mu). It is a higher education institution authorized to award Master’s and Bachelor’s degree. Currently, there are 17 colleges, 80 master's degree programs, 63 under-graduate programs concerning literature, science, economics, management, art, physical education, etc., forming an educational system which is able to train postgraduates, undergraduates and overseas students. Currently, there are over 28,000 students enrolled and over 1700 teachers including more than 650 professors and associate professors.

Unit 610 North Tower, Building C Raycom Infotech Park Haidian District Beijing, 100190 ChinaClarivate is a leading global provider of transformative intelligence, including Cortellis and Decision Resources Group ("DRG"). We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com

No.44, Life Science Park Road Beijing, Changping ChinaClickChem Technology offers custom synthesis, diversity library design, process development, and analytical chemistry services in addition to supplying intermediates.

Beijing, China Beijing, Beijing, 100190 ChinaComMedX （Computational Medicine Beijing） is a startup that focused on developing next-generation technologies for small-molecules drug discovery. Currently, employees are located in Beijing, China. By combing novel X-ray crystallography/cryo-EM structures, new commercial accessible chemical libraries building, ultra-large docking screening methods, a hierarchical lead optimization pipeline, and the artificial intelligence/machine learning algorithms, ComMed is advancing a new lead discovery platform to boost the first-in-class drugs discovery for biotech companies. ComMed is working to bring innovations for navigating new chemical spaces for new targets at unparalleled low cost and fast speed.

Beijing, ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

6th floor, Yilan Building No.28 Huojü Street, Zhong Guan Cun Science Park Beijing, Changping District, 102200 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

6th floor, Yilan Building No.28 Huojü Street, Zhong Guan Cun Science Park Changping District, Beijing, 102200 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

Building 2, Court 9, Medical Park Road, Life Science Park Changping District Beijing, Beijing, 102200 ChinaDeepKinase pioneers in proteomics for drug discovery and development, with two leading products, DoTD and DoTK. DoTD provides mass spectrometry based quantitative proteomics to assist TPD therapeutics; results are featured in numerous IND filings. DoTK offers patented tyrosine phosphoproteomics technology, vital to understand kinase activities and signaling in cancer and immune diseases. DeepKinase is a global front-runner in proteomics analysis, driving novel research, biomarker discovery, and personalized medicine in pharmaceutical industry.

7th Fl, Digital China Building, No 16 Haidian District, Beijing, Beijing ChinaOur company operates from Beijing and Boston and specialize in oncology and rare diseases data. Specifically, we provide: 1) RWE and HEOR using data from Chinese oncology hospitals and rare disease registries; 2) Healthcare information technology, Big Data, medical cloud service, data capturing/cleaning /processing/analysis; and 3）patient (OS / PFS), physician and KOL surveys.

Chaoyang District Beijing Shi, 100096 ChinaA next-generation China-based clinical CRO with more than 350 staff who deliver to global quality standards. Led by a select team chosen from leading multinational biopharma firms, we are committed to helping companies leverage the clinical development and regulatory opportunities created by China's radical regulatory liberalization and full ICH membership. We serve leading Western multinationals, innovative Chinese market leaders as well as emerging biotechs from both China and the West. Our serves can be delivered a project basis or as an end-to-end outsourcing partner for all clinical and regulatory needs.

Xicheng District, Beijing, ChinaE Living Pharmaceutical offers clinical research services.

8/F Zhong Tian Building, No.5A De Wai Street, Xic Beijing 100088 ChinaExcel PharmaStudies provides biometrics, clinical analysis, clinical trials, database systems, drug discovery support, and packaging.

Fengtai District, Beijing, ChinaFly Tech Pharm provides compound synthesis, optimization, structural analysis, and clinical research.

Beijing, ChinaGenMax Biomed offers toxicology, pathology, virtual drug development, radio-imaging, immunoconjugation, and quality control.

5 Tongji Middle Rd, BDA Beijing, Bejing, 100010 ChinaGlotope stands firm in its local roots while reaching out to the global market. With dual headquarters in Beijing and Chengdu, we operate state-of-the-art radiopharmaceutical R&D and production centers in Jiangsu, Guangdong, and Sichuan. Our facilities boast over 100 advanced R&D and production hot cells and qualifications for handling a variety of radionuclides, including but not limited to 225Ac, 177Lu, 212Pb, 68Ga, 18F, 64Cu, 203Pb, and 89Zr. At Glotope, we provide adaptive and all-encompassing support to our global clientele, spanning the full spectrum of radiopharmaceutical development. From expedited PCC validation to IND submissions in China and US, from clinical trials to NDA approvals, and commercial-scale manufactering, we guarantee seamless and efficacious transitions at every phase. Our unparalleled expertise and cutting-edge facilities empower us to deliver superior solutions and prompt outcomes, driving innovation and revitalizing the radiopharmaceutical industry worldwide..

Room 1711, Han Wei Plaza, No.7 GuangHua Road, Chao Yang District, Beijing, 100020 ChinaHuaFaMei specializes in the export and distribution of API, intermediates, plant extracts, and chemical raw materials.

Building 10, Zone c, Yiyuan Science and Technology Park Haidian District, Beijing, ChinaKangso Medical Inspection was founded in 2010 and got Ministry of Health P.R. China certificated in March 6, 2012. Kangso Medical Inspection and its whole-owned subsidiary, Huakang Gene Institute, carry diverse responsibilities on clinical molecular genetics, specifically on the detection of virulence gene of genetic disease and non-invasive prenatal diagnosis. Our IR&D Bestseq is the most accurate, economic and efficient targeted gene capture sequencing technology based on NGS. At present, we are working with China’s top-ranked hospitals in the detection of more than 400 genetic diseases. Rather than testing single genes, we have genetic testing panels covering Hereditary Cardiovascular Diseases, Genetic Endocrine and Metabolic Diseases, Genetic Nervous System Diseases, Hereditary Eye Diseases, Genetic Skin Diseases and Germline Cancer.

Building 14, VPark, No. 18 of the13th Kechuang Street, Etown, Tongzhou, Beijing, 100176 ChinaFounded in 2010, ICE Bioscience has been committed to delivering excellent services in early drug discovery, especially in Immuno-Oncology, Cardiovascular, and CNS diseases areas. ICE Bioscience has fully established service departments of Biology, Electrophysiology, Biochemistry, ADME/DMPK, in vivo pharmacology, and R&D Center to develop innovative assays and platforms. We have 75,000+ sqft of lab space, and 300+ dedicated and experienced drug discovery professionals. We have wide target-based panel screening platforms that are ready to use, expanding diverse techniques related to Biology and Pharmacology, to support various drug discovery purposes for different indications and clinical needs. Currently, ICE Bioscience provides fully validated assay solutions for 100+ ion channels,1000+ Kinases/enzymes,150+ GPCRs,40+ nuclear receptors assays, and epigenetics and DDR targets, all of which cover most of the druggable targets. We already established platforms for protein production, Biochemistry, Immunology, Oncology, Electrophysiology, in vitro Cardiac and CNS Pharmacology, off-target safety evaluation, Cardiac safety evaluation, DMPK, etc. We make the DMTA cycle (Design-Make-Test-Analysis cycle) run efficiently and risk-free for our client’s innovative drug discovery pipelines. ICE Bioscience provides cost-effective, customized, fast-TAT, and flexible FTE (and hybrid) working models. Currently, we are providing services to over 700 biotech and pharmaceutical companies global wide. Our expertise and experience in preclinical biology service provides not only high-quality results but also help our clients to manage and reduce potential risks of their early drug discovery pipelines and programs. Our vision is to fully support our clients to transform the horizon of their therapeutic areas. Key features of ICE Bioscience’s drug discovery service: • Whether you're delving into biochemical pathways or exploring cellular functionalities, our target-based assays deliver robust data, empowering researchers to make informed decisions in drug discovery and development. • Whether you're assessing compound stability, metabolism, or bioavailability, our DMPK capabilities empower you with the knowledge needed for optimizing lead compounds and advancing them toward successful clinical outcomes. • Unique and specialty assays and platforms. We proudly offer: SafetyOne-44, and SafetyMax-90 panels for off-target safety screening and to reduce risks in the later stage of drug discovery pipelines; ICE Bioscience also offers 416 kinase panel, which is the largest kinase panel using activity assay formats. • Our translational biology expertise encompasses a spectrum of translational studies, including biomarker identification, target validation, and mechanism-of-action investigations. By seamlessly integrating molecular and cellular findings, we facilitate the transition of promising candidates from the laboratory to clinical settings. • Scientific and regulatory expertise: staff at ICE Bioscience has a staff of Ph.D. and medical professionals (>30%) highly experienced in drug discovery and have innovative mindsets to help clients to develop unique assays and solutions for novel target screening. With 13+ years of service legacy in early drug discovery, ICE Bioscience’s mission is to expedite and reduce the risk of our client’s drug discovery pipelines and contribute to the improvement of global healthcare with our advanced technologies and dedicated science team.

Beijing, ChinaThe Institute of Molecular Medicine at Peking University (IMM PKU) is an autonomous research institute with a special emphasis on systematic approaches to cardiovascular problems.

Beijing, ChinaiPhase Pharma Service (IPHASE) is a “specialized, novel, and innovative” high-tech enterprise integrating research, development, production, sales, and technical services of innovative biological reagents. Leveraging extensive knowledge and passion for scientific research, our scientific team is committed to supplying quality innovative biological reagents to scientists worldwide and assisting researchers throughout their scientific endeavor to help achieve their research objectives. Pursuing the R&D ideal of “innovative reagents, researching the future”, IPHASE established multiple R&D facility, sales center, warehouse and distribution partners in China, United States, Europe and East Asian countries – covering more than 12,000 square feet.

18AEF, Building-D, Majestic Garden, No.6 Middle of Beisihuan Road Beijing, Chaoyang 100029 ChinaJ&K Scientific supplies fine chemicals and offers custom synthesis services.

No.5 Rongjingdong St. Beijing Economic and Development Area Beijing, Beijing, 100176 ChinaFounded in 1995, JOINN Laboratories (China) Co., Ltd. (JOINN Laboratories, Stock Code: 603127.SSE/6127.HK) is dedicated to providing drug R&D CRO outsourcing services. Headquartered in Beijing, JOINN has subsidiaries in Beijing, Suzhou, Shanghai, Chongqing, Wuzhou and Guangzhou in China, and Richmond (CA) and Worcester (MA) in the United States, with over 2000 professionals. JOINN has built a thorough quality management system complying with international standards: CNAS/ILAC-MRA certification, NMPA, US FDA, OECD, Japan PMDA and Korean MFDS GLP certification and international AAALAC accreditation. JOINN provides customized services to the sponsor’s specific needs for non-clinical safety assessments, clinical trials, registrations, and pharmacovigilance, covering the entire spectrum from development to final drug registration. JOINN also provides services in animal feed and veterinary medicine evaluation, pesticide evaluation, medical device evaluations, and more.

Room 7-2-302 Hui Long Sen Tech Park No99 14th KeChuang St. BDA Beijing, Beijing, 100176 ChinaK2 Oncology is a R&D high tech Biotech Corp with its headquarter in Beijing, China. The company focus on novel tumor organoids cell culture technology. Based on patented ViaCyte cancer organoids culture platform, K2 Oncology has established unique 3-D culture systems similar to in vivo micro-environments. K2 Oncology can offer >2500 tumor organoids model collections for cancer research and therapeutic drug discovery.

Room 401, building 3, Jiu Cheng Tech Park district three Daxing, Beijing, 101111 ChinaK2 Oncology is a R&D high tech Biotech Corp with its headquarter in Beijing, China. The company focus on novel tumor organoids cell culture technology. Based on patented ViaCyte cancer organoids culture platform, K2 Oncology has established unique 3-D culture systems similar to in vivo micro-environments. K2 Oncology can offer >2500 tumor organoids model collections for cancer research and therapeutic drug discovery.

Room 401, building 3, Jiu Cheng Tech Park district three 88 Jinghai five Street Daxing, Beijing, 101111 ChinaK2 Oncology is a R&D high tech Biotech Corp with its headquarter in Beijing, China. The company focus on novel tumor organoids cell culture technology. Based on patented ViaCyte cancer organoids culture platform, K2 Oncology has established unique 3-D culture systems similar to in vivo micro-environments. K2 Oncology can offer >2500 tumor organoids model collections for cancer research and therapeutic drug discovery.

No.6 Rongjing East Street, BDA, Beijing 100176, ChinaKawin Technology offers custom manufacturing services.

FL-4, Building A5, International Enterprise Community, Tianjin, China Tianjin, Tianjin, 301700 ChinaKMD Bioscience Co., Ltd. was established in Tianjin, China in 2014. The founder team has many years of experiences in human drug research and development. KMD Bioscience takes research & development as the foundation of its value and focuses on providing high-quality products and drug-antibody discovery services for global scientists, research institutes and pharmaceutical companies. As a high-tech enterprise in China, KMD Bioscience has successfully obtained the ISO9001:2015 quality management system certification and national patent pilot laboratories. At present, the company has more than 30 patents and 2 registered trademarks. KMD Bioscience provides more than 600+ technical service consulting, custom service design and project delivery for research institutes, hospitals, pharmaceutical companies and biological companies worldwide every year. At the beginning of its establishment, KMD Bioscience started from the phage display technology platform to provide high-quality antibody discovery services, and gradually established stable cell line construction and screening, natural protein extraction and fermentation, and recombinant protein custom expression services, a multi-species antibody discovery platform. Based on the above-mentioned major R&D platforms, KMD Bioscience has successfully developed many related reagentss such as recombinant proteins, antibodies, antibody drug similars, industrial enzymes, and diagnostic raw materials for scientific research and new drug discovery.

Room 609, No.3 Building, Yizhuang Biomedical Garden, No. 88, Kechuang Six Street, Yizhuang Economic and Technological Development East Zone Beijing, Beijing, 101111 ChinaKyinno Biotechnology is a preclinical contract research operation (CRO) dedicated to oncology drug discovery service and customized product development, with a focus on immuno-oncology and next-generation kinase inhibitor discovery. Our strength is the strong R&D team with decades of experience in the pharmaceutical and biotechnology industry in the United States. We have comprehensive development capability to construct stable cell lines engineered in unique and new targets through CRISPR Knock-in/Knock-out technology. Our animal facilities with a capacity of 1,000 cages (5,000 mice)are located in Beijing. We can perform 60 projects at the same time. Our service platforms include: 1. Off-the-shelf stable cell lines More than 3000 engineered cell lines are available (in stock) in our Waltham logistic center (MA, United States). The lead time will be 2~3 business days in the United States and about 2 weeks in Europe. 2. Custom cell line engineering Background cell lines. Over 700 human tumor cells and other animal cells are available for engineering. Technology. CRISPR Knock-in/Knock-out technology (homozygous clone and heterozygous clone) for site-specific integration. Overexpress gene/target using lentivirus vector transfection Standard deliver pool/single clone with validated PCR sequencing/Mycoplasma free/STR/HiBit test/Western Blot (WB) validation/siRNA test. 2. Cell-based assay validation and drug screening(small molecule compound and PROTACs) Cell proliferation assay(cell cytotoxicity assay).3D cell proliferation assay and 2D cell proliferation assay FACS binding assay/FACS internalization assay/ Immunol pathway assay/ ELISA assay ADCC cell-based bioassays/antibody-dependent cellular phagocytosis (ADCP) assays 3. Drug combination (in vivo combination and in vitro combination) integrated with bioinformatics analysis. 4. Pharmacology in vitro and in vivo study service, PK/PD efficacy studies in our ideal immunodeficient models. Hundreds of cell line-derived xenograft (CDX) mouse models are validated and are ready to test new anti-cancer drugs. BaF3 xenograft models Syngeneic models PBMC humanized mouse model Luciferase tumor model IVIS Imaging/Whole blood, spleen, and lymph node analysis/Chemotherapy validation 4. Phage display library and hybridoma technology for antibody drug discovery Humanization and affinity maturation Draggability and immunogenicity evaluation Nanobody Hybridoma services Single B cell sequencing 5. Common light chain technology 6. Cancer cell panel compound profiling and biomarker discovery 7. Mega screening platform HRD Homologous recombination deficiency (HRD) score of the cell lines was calculated and 100 cell lines with high HRD scores were selected for compound screening. Kinase BaF3 cell panel screening. With our gene-editing expertise, KYINNO has constructed over 700 BaF3 cell lines which harbor various hotspot kinase drug targets. Our dedicated cell-based assay team daily handles hundreds of BaF3 cell lines and thousands of test articles. Most of the engineered BaF3 cell lines are suitable for in vivo efficacy studies. By in vitro screening, the compounds showing good potency can be quickly selected for further in vivo efficacy study without any delay in our one-stop service. Target: EGFR family, VEGFR family, FGFR family, EML4, ALK, NTRK family, FLT3 family, ROS1, HER2, HER3, BCR-ABL, cKit, RET, TAM family, KRAS, NRAS, HRAS, IGF1R, TPR-Met, etc. Innovative membrane proteins screening array MPSA-AB5000 The specificity of antibodies, CAR-T cells, and other biologic therapeutics to their binding targets is an important step in the evaluation process of drug development. MPSA-AB5000 is a high-throughput cell-based platform for identifying the targets of antibodies and other ligands that bind to human membrane proteins for determining the specificity and preclinical safety of antibodies, CAR-T cell therapies, ADC, and other biotherapeutics. Here are some key features and benefits of AB5000: Unparalleled Antibody Specificity Screening. Our advanced platform allows for screening a wide range of human membrane proteins, which are critical for accurate specificity assessment. Early Off-Target Screening. The largest collection of human membrane proteins is natively expressed in live cells. You can conveniently determine the specificity and preclinical safety of biotherapeutics. Rapid, Simple, and Highly Sensitive. This cutting-edge technology provides rapid, simple, and highly sensitive results by measuring binding through ADCC via a luciferase reporter cell line. The wash-free strategy reduces false negatives, and signal amplification makes remarkable discrimination. Comprehensive Preclinical Safety Assessment. Our products catalogs: Kinase cell line Immune molecule cell line Gene Editing Cell line Engineered reporter cell lines Luciferase cell line Fluorescence-labeled cell line Drug-resistant cell line Antibody and proteins with fully validated functions in reporter cell lines Isotype control Therapeutic antibody Hybridoma Recombinant protein

Room 2510B, Level 25, JING GUANG Centre, Hujialou, Chaoyang District Beijing, 100027 ChinaLinical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.

Room 2510A, Level 25, JING GUANG Centre, Hujialou, Chaoyang District Beijing, Beijing, 100027, ChinaLinical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.

8 Haidian Street Beijing Shi, 100080 ChinaAs a global leading artificial intelligence and medical big data platform, LinkDoc has the largest medical big data resource database in China and the most advantageous technical support service system. Over the years, LinkDoc relied on its core technology advantages and advanced artificial intelligence technology in the integration, processing and analysis of medical big data, to serving the community, government departments, and medical industry, providing high-quality medical big data solutions as well as artificial intelligence assistant decision-making systems (assisting management decisions, assisting clinical research, AI intelligent medical treatment), patient-wide process management, hospital public opinion monitoring and brand building, medical device research and development, and insurance control Fees and other integrated services.

Zone BC, 8/F, Block A, Zhonggang International Plaza, No. 8, Haidian Street Haidian District, Bejiing, 100080 ChinaAs a global leading artificial intelligence and medical big data platform, LinkDoc has the largest medical big data resource database in China and the most advantageous technical support service system. Over the years, LinkDoc relied on its core technology advantages and advanced artificial intelligence technology in the integration, processing and analysis of medical big data, to serving the community, government departments, and medical industry, providing high-quality medical big data solutions as well as artificial intelligence assistant decision-making systems (assisting management decisions, assisting clinical research, AI intelligent medical treatment), patient-wide process management, hospital public opinion monitoring and brand building, medical device research and development, and insurance control Fees and other integrated services.

Suite 22, Hyundai Motor Tower, 38 Xiaoyun Road, Chaoyang District, Beijing, ChinaLutronic provides high-quality, affordable medical lasers.

Room 712, North Real Estate Building, No.81 Zizhuyuan Road, Haidian District Beijing, China 100089Meryer Chemical Technology specializes in custom synthesis and supplies organic, inorganic, and biochemical reagents.

17 F, Tower B, Jinma Building, No.38 Xueqing Road Haidian District Beijing ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

Room 101, Building 301, Zone A10 (Electronic Technology Town) Jiuxianqiao North Road Chaoyang District, Beijing, 100020 ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

21F, Tower B, Jinma Building , No.38 Xueqing Road, Haidian District, Beijing, 100083, ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

Room 101, Buildi Chaoyang District, Beijing, Chinang 301, Zone A10 (Electronic Technology Town) Jiuxianqiao North Road, Beijing, 100015 ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

B07/B08/B09, Building, Wuqing Entrepreneurial Base, Tianjin Tianjin, 301700 ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

Room 101, Building 301, Zone A10 (Electronic Technology Town) Jiuxianqiao North Road, Chaoyang District, Beijing, China Beijing, 100015 ChinaWith a number of major investments under way, Novogene is equipped with cutting-edge high-throughput sequencing platforms, including 10 HiSeq X, 10 HiSeq2500/2000, 1 NextSeq 500, and 4 Miseq sequencing systems. Novogene also operates computing facilities which provide 22.8T flops performance, 12.33TB total memory and 2.3PB high-speed storage capacity. Novogene provides services for customers from domestic and foreign universities, research institutes, hospitals, and pharmaceutical enterprises. Within the past three years, Novogene has completed numerous major projects, with findings acknowledged and published by top-ranked journals such as Science and Nature series. Through working in partnership with everyone from research institutes to health care hospitals, Novogene hopes to cooperate with you to develop the unlimited potential of ever changing world of genomics.

103 Beiqing Rd, Haidian DistrictOkeanos offers custom synthesis services, specializing in nucleoside chemistry.

Xueyuan Road No.38, Beijing, Haidian District, 100191 ChinaThe Department of Laboratory Animal Science founded in December, 1984. This department has about 80 personnel in total, including high-title researchers, technicians, and senior laboratory animal feeders and technicians. We are in line with the working principles that are “teaching and researching services-focused, assuring qualified and sufficient laboratory animal provision and all-directional laboratory animal services”, strives to work and make the department to be the important foundation and service platform for the health science in teaching and researching. This department has its own offices, logistical rooms, SPF Animal Laboratory, SPF Animal Breeding Room, Conventional Animal Laboratory and Laboratory Animal Research Laboratory.

Xueyuan Road No.38, Haidian District, Beijing Postal code: 100191 ChinaThe Department of Laboratory Animal Science founded in December, 1984. This department has about 80 personnel in total, including high-title researchers, technicians, and senior laboratory animal feeders and technicians. We are in line with the working principles that are “teaching and researching services-focused, assuring qualified and sufficient laboratory animal provision and all-directional laboratory animal services”, strives to work and make the department to be the important foundation and service platform for the health science in teaching and researching. This department has its own offices, logistical rooms, SPF Animal Laboratory, SPF Animal Breeding Room, Conventional Animal Laboratory and Laboratory Animal Research Laboratory.

49 North Garden Rd. Beijing , Haidian District, 100191 ChinaPeking University Third Hospital Medical School Department of Laboratory Animal Research

Beijing Shi ChinaPeking University Third Hospital Medical School Department of Laboratory Animal Research

32 Kexue Yuan Road Zhongguancun Life Science Park Beijing, Changping District, 102206 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials

No 6 Taihe Road, BDA Beijing, 100176 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials

Room 510, No. 19, South Ronghua Road BDA, Beijing, China, 100176 ChinaPHT International is a 32-year-old, woman-owned, minority business headquartered here in Charlotte. We specialize in the supply of fine chemicals and intermediates to industries including cosmetics, personal care, polymers, industrial applications, and pharmaceuticals. Our global supply capabilities include in-house production at our facilities in China, joint ventures in China and India, and partnerships with select manufacturers that provide advanced fine chemical technologies.

NO. 52 Northwest 4th Ring Road, Haidian District, Beijing, China 100080Plexera provides label-free screening services on the high-throughput PlexArray HT screening platform, providing flexibility in project size and experimental design.

No. 66 Jindai Road, Zhongguancun Environmental Protection Science and Technology Demonstration Park, Haidian District, Beijing Beijing, 100095 ChinaPony Testing is an industry leader, which was founded in 2002. The headquarter locates in Beijing. Now it has developed into a sizeable comprehensive testing group with more than 8000 employees, 30 large experimental bases, and more than 100 wholly-owned subsidiaries and branches all over the country. Pony Testing has a national enterprise technology center, a biomedical engineering laboratory, an engineering and technology research center, and a post-doctoral research station. So far, Pony Testing has obtained more than 300,000 analytical methods and has conducted more than 27 million tests annually. On September 16, 2020, Pony Testing was successfully listed on the GEM (Growth Enterprises Market) of Shenzhen Stock Exchange, and became the first third-party inspection and certification institution after the GEM registration system with the stock code of 300887.

Room 1001, Sunjoy Mansion Chaoyang 100020, Beijing, China Princeton Instruments (PI) designs and manufactures high-performance CCD, ICCD, EMCCD, emICCD, and InGaAs cameras; spectrographs; and optics-based solutions for the scientific research, industrial imaging, and OEM communities. We take pride in partnering with our customers to solve their most challenging problems in unique, innovative ways. PI operates as a unit of Roper Technologies, a diversified growth company and a constituent of the S&P 500, Fortune 1000, and Russell 1000 indices. Roper provides engineered products and solutions for global niche markets, including water, energy, transportation, medical, education, and SaaS-based information networks. Princeton Instruments has two U.S. manufacturing facilities, one located in New Jersey (Trenton) and one in Massachusetts (Acton). Our worldwide sales and service organizations in Germany, France, the United Kingdom, Japan, China, and Singapore provide sales support and discuss application requirements in addition to being your local contacts for order processing and service. Capabilities: Princeton Instruments possesses core technological capabilities in several key areas: Scientific Imaging: High-performance CCD, ICCD, EMCCD, emICCD, and InGaAs cameras for an expansive range of applications, including astronomy, BEC, combustion, PIV, single-molecule imaging, surface and materials analysis, PSP, and nanotechnology. Spectroscopy: A wide selection of state-of-the-art CCD cameras, spectrographs, monochromators, and integrated systems for Raman, LIBS, absorption, fluorescence, NIR/SWIR, and luminescence spectroscopy. X-ray Imaging: Advanced scientific-grade CCD cameras for x-ray applications such as EUV, lithography, XRS, plasma, diffraction, microscopy, and tomography. Optics & Coatings:

Beijing, Beijing ChinaProswell Medical offers non-clinical and clinical services.

Unit 302, Building 15, No. 8 Liangshuihe 2nd Street Han's Enterprise Bay, BDA, Beijing, 100176 ChinaIQVIA Laboratories, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. At IQVIA Laboratories, we offer a range of genomic services to support drug discovery, precision medicine and clinical development. Our industry-leading genomic services team can help you uncover invaluable insights from your data. Our experts design smarter studies to help you: We provide whole genome to focused set gene expression profiling and genotyping assays along with DNA and RNA sequencing services, sequence enrichment technologies and bioinformatics analysis expertise to support all product development needs. We offer tailored solutions for challenging specimens such as whole blood and FFPE tissues, as well as nucleic acid isolation and data analysis services. Through carefully orchestrated analyses, we work with you to choose platforms and assays that will distinctly fit your needs, and then use them to deliver valuable, informative data. Our solutions support our clients’ clinical trial and research efforts across the industry spectrum. We work with pharmaceutical, biotechnology, medical device/diagnostic, academic, government and nonprofit clients using a wide array of technology platforms, so that we can determine exactly what works best for you without sacrificing quality or efficiency. Our quality system follows CLSI guidelines and our CLIA-certified and CAP Accredited laboratory supports GLP compliance. Accelerate drug development with genomic know-how®. Partner with our experts to determine the best methods to obtain the data you need to solve complex biological problems, realize efficiencies, mitigate risks and improve your clinical outcomes.

4A/F, Building A, Wantone Center, No.6 Jia, Chaoyangmenwai Avenue, Chaoyang District Beijing, 100020 ChinaRexun Pharma is a drug discovery outsourcing company that provides high-quality, integrated research and development services to biopharmaceutical clients. Expertise include medicinal chemistry, custom synthesis, and API/intermediate/reagent supply.

7F, Building 12, Yitron Hi-Tech Innovation and Technology Park No.2 Kechuang Sixth Street, Beijing Yitron Economic and Technological Development Zone Beijing, Beijing, 100176 ChinaSAFE Pharmaceutical was established in 2016, based on national level drug research and development units such as the Institute of Drug Innovation of the Chinese Academy of Sciences, etc. SAFE pharmaceutical is committed to become a world-class one-stop medical CRO service platform. 

No.2 Shangdi Information Road Room 11E, Building 2 Beijing, Beijing, 100085 ChinaBeijing SBS Genetech Co.,Ltd. is one of the earliest Chinese companies providing custom oligonucleotides synthesis, gene synthesis and custom peptide synthesis. Since we founded in 2000, we have been committed to use technology to create a future that we are a proud of. Over decades, by providing safer, higher quality and more affordable products, we have served top researchers in more than 40 countries, empowering them to create new fundamental knowledge in the field of biology. Today we not only provide custom oligos, gene synthesis and peptide synthesis services, we also offer the following products: DNA synthesis products, nucleic acids isolation & purification kits, DNA molecular weight markers, PCR-Related Products, RNA-Related Products, gene manipulation products, etc. With its remarkable characteristics, we have acquired a leading position in such fields, and contributed to life science development together with wonderful researchers. Thousands of papers have been published in the world's top academic journals with our products. From genome sequencing of E. coli to human beings, from basic molecular cloning technique to CRISPR-Cas-mediated genome editing, from earliest combinatorial synthesis of genetic networks to chemical synthesis of two S. cerevisiae chromosome arms, we have been witnessing the miracle created by life science throughout past decades. We are proud that we realized our dream and we believe the future will be brighter with our joint efforts.

Room 202, Building 2, No.1, Shangdi 4th Street, Haidian DistrictBeijing SBS Genetech Co.,Ltd. is one of the earliest Chinese companies providing custom oligonucleotides synthesis, gene synthesis and custom peptide synthesis. Since we founded in 2000, we have been committed to use technology to create a future that we are a proud of. Over decades, by providing safer, higher quality and more affordable products, we have served top researchers in more than 40 countries, empowering them to create new fundamental knowledge in the field of biology. Today we not only provide custom oligos, gene synthesis and peptide synthesis services, we also offer the following products: DNA synthesis products, nucleic acids isolation & purification kits, DNA molecular weight markers, PCR-Related Products, RNA-Related Products, gene manipulation products, etc. With its remarkable characteristics, we have acquired a leading position in such fields, and contributed to life science development together with wonderful researchers. Thousands of papers have been published in the world's top academic journals with our products. From genome sequencing of E. coli to human beings, from basic molecular cloning technique to CRISPR-Cas-mediated genome editing, from earliest combinatorial synthesis of genetic networks to chemical synthesis of two S. cerevisiae chromosome arms, we have been witnessing the miracle created by life science throughout past decades. We are proud that we realized our dream and we believe the future will be brighter with our joint efforts.

Beijing, Beijing ChinaScilight-Peptide offer purification and custom peptide synthesis services.

No.1, Nan-Ke 8th RoadScinoPharm offers API intermediates, stability testing, peptide isolation, purification, and extraction with custom synthesis services.

Haidian District, Beijing Anning Zhuang Road 186 House new research building Guanghua Pioneer Park, ChinaShanghai Megiddo Biological Pharmaceutical Co., Ltd. from the initial first-generation sequencing service started, gradually extended to high-throughput sequencing, bioinformatics service bioinformatics cloud computing, medical laboratory and bio-medicine. Under the current five subsidiaries: United States and Kyrgyzstan science and technology, information technology Sanger, Megiddo Medical Control, more than Chinese biomedical, Megiddo Institute. Where the United States and Kyrgyzstan are setting up experimental base in Shanghai, Beijing and Guangzhou, sales network throughout the country. Megiddo organism has first-class sequencing platform (HiSeq2500, HiSeq 4000, MiSeq, ABI 3730XL, ABI 7500) and advanced MS platforms (Q-Exactive, Triple TOF 5600, Obitrap Fusion, QTRAP 5500), specializes in genome sequencing, transcriptome sequencing, metagenomic sequencing, single-cell sequencing, sequencing of the target area, exon sequencing, high-throughput genome sequencing technology services and proteomics, metabolomics and other technical services, but also provides multi-omics solutions that meet various research demand. Megiddo biological building high-performance computing clusters (HPC), the Dell rack-mounted servers, blade servers and lustre parallel file system. Computing capacity of up 29.4Tflops, total memory size is 10TB, high-performance storage capacity of 2PB. For the storage, processing and subsequent analysis of massive biological data to provide a stable, efficient hardware support.

B1,National Institute of Biological Sciences，Changping District Beijing, China, 102206 China• 8+ state-of-the-art 300 kV cryo-EM instruments, enabling high-quality structural analyses with advanced technology • 2000+ successful projects completed, including 1200+ structures resolved below 3.5 Å, with a record resolution of 1.4 Å • High versatility, with proven capability to analyze proteins as small as 51 kDa • Trusted by 1400+ institutions worldwide, supporting a broad range of global research programs

B1,National Institute of Biological Sciences，Changping District Changping District Beijing, China, 102206 China• 8+ state-of-the-art 300 kV cryo-EM instruments, enabling high-quality structural analyses with advanced technology • 2000+ successful projects completed, including 1200+ structures resolved below 3.5 Å, with a record resolution of 1.4 Å • High versatility, with proven capability to analyze proteins as small as 51 kDa • Trusted by 1400+ institutions worldwide, supporting a broad range of global research programs

Bio2 Innovation Center, ZGC Life Science Park Changping District Beijing, China, 102206 China• 8+ state-of-the-art 300 kV cryo-EM instruments, enabling high-quality structural analyses with advanced technology • 2000+ successful projects completed, including 1200+ structures resolved below 3.5 Å, with a record resolution of 1.4 Å • High versatility, with proven capability to analyze proteins as small as 51 kDa • Trusted by 1400+ institutions worldwide, supporting a broad range of global research programs

No.18 Kechuang 10th St, BDA Building 9, Jing Dongbei Technology Park Daxing District, Beijing, 100176 ChinaSino Biological is a global leader in recombinant protein and antibody production and CRO services for life sciences research and drug development. Its facilities include the Center for Bioprocessing (C4B) in Houston, Texas, which specializes in mammalian cell-based protein and antibody production, and SignalChem Biotech (SCB) in Vancouver, Canada, focusing on kinase-related reagents, stable cell line development, and therapeutic discovery. With a U.S. office providing localized support, Sino Biological ensures innovative, high-quality solutions for global academic and industrial clients.

Beijing, Beijing ChinaSinocelltech is specialized in development of cutting-edge process and manufacturing technologies for biological products such as recombinant proteins, monoclonal antibodies, vaccines, and gene therapy products.

11/F,Central Tower,Chemsunny World Trade Center,28 Fuxingmennei Beijing, 100031 ChinaSinochem specializes in manufacturing and export of pharmaceutical intermediate and API.

No. 3-707 North Yongchang Road BDA Beijing 100176 ChinaSinoGenoMax offers servics for DNA sequencing, SNP discovery and validation, STRs analysis, real time quantitative PCR, protein expression and purification and recombinant adenovirus construction.

Floor 2, Building 14, Yard 20, Guangde Street, Beijing Economic and Technological Development Zone (Daxing) Beijing City, 100163 ChinaSmooth Drug Development (SDD) full-service CRO that provides support to pharmaceutical and biotechnology companies in drug development from concept to post-marketing surveillance. Countries of operation include: Europe: Baltic States Belarus Bulgaria Hungary Germany Moldova Russia Serbia Spain Slovakia Asia: India Kazakhstan Uzbekistan

No.319 Unit 3, YongLi International Mansion, GongTiBeiLu 21 BeijingSun Health is a global outsourcing service provider for the pharmaceutical,biotechnology and medical device industries. Our business model offers solutions of success,from the lab to the market.We understand the need to move up in the value chain,and enjoy evolving into a solution provider,rather than being just a CRO.

LiGoKeJi 9007 Zhongguancan South 5 Haidian, Beijing, 100086 ChinaSun Health is a global outsourcing service provider for the pharmaceutical,biotechnology and medical device industries. Our business model offers solutions of success,from the lab to the market.We understand the need to move up in the value chain,and enjoy evolving into a solution provider,rather than being just a CRO.

12F, Health Work, No.9 Building of No.35 of HuayuanNorth Road, Haidian District, Beijing Beijing, 010 ChinaTianjin Happy Life Tech Co.,Ltd is a legal entity registered in People’s Republic of China in January 2017, with a registered capital of 30 million Chinese Dollars. The company has invested over 10 million Chinese Dollars into Research and Development and has more than 50 scientists and technicians in various fields. Our company has developed partnership with third parties on several medical data researches since established. As the rightful owner/licensed user of the technology platforms listed below, Tianjin Happy Life Tech Co., Ltd. is lawfully own/authorized to use these platforms in the world-wild & People’s Republic of China. Benefited from these platforms, our company is equipped to provide effective solutions for pharmaceutical companies at the highest professional level, including but not limited to marketing insight/perspective delivering, opportunity discovering, Real-World Evidence(RWE) excavation (data mining) and multicenter trials in Real-World Study(RWS). Tianjin Happy Life Tech Co.,Ltd. is committed to compliance with the laws and regulations in the People's Republic of China. Neither Party shall disclose any Confidential Information to any third party in any way without Tianjin Happy Life Tech Co.,Ltd.’s prior written consent.

Hua Yuan Bei Lu Beijing Shi ChinaTianjin Happy Life Tech Co.,Ltd is a legal entity registered in People’s Republic of China in January 2017, with a registered capital of 30 million Chinese Dollars. The company has invested over 10 million Chinese Dollars into Research and Development and has more than 50 scientists and technicians in various fields. Our company has developed partnership with third parties on several medical data researches since established. As the rightful owner/licensed user of the technology platforms listed below, Tianjin Happy Life Tech Co., Ltd. is lawfully own/authorized to use these platforms in the world-wild & People’s Republic of China. Benefited from these platforms, our company is equipped to provide effective solutions for pharmaceutical companies at the highest professional level, including but not limited to marketing insight/perspective delivering, opportunity discovering, Real-World Evidence(RWE) excavation (data mining) and multicenter trials in Real-World Study(RWS). Tianjin Happy Life Tech Co.,Ltd. is committed to compliance with the laws and regulations in the People's Republic of China. Neither Party shall disclose any Confidential Information to any third party in any way without Tianjin Happy Life Tech Co.,Ltd.’s prior written consent.

Building 22, Phase III, Lincui Xili, Chaoyang District, Beijing Beijing, Beijing, 100020 ChinaTianjin Happy Life Tech Co.,Ltd is a legal entity registered in People’s Republic of China in January 2017, with a registered capital of 30 million Chinese Dollars. The company has invested over 10 million Chinese Dollars into Research and Development and has more than 50 scientists and technicians in various fields. Our company has developed partnership with third parties on several medical data researches since established. As the rightful owner/licensed user of the technology platforms listed below, Tianjin Happy Life Tech Co., Ltd. is lawfully own/authorized to use these platforms in the world-wild & People’s Republic of China. Benefited from these platforms, our company is equipped to provide effective solutions for pharmaceutical companies at the highest professional level, including but not limited to marketing insight/perspective delivering, opportunity discovering, Real-World Evidence(RWE) excavation (data mining) and multicenter trials in Real-World Study(RWS). Tianjin Happy Life Tech Co.,Ltd. is committed to compliance with the laws and regulations in the People's Republic of China. Neither Party shall disclose any Confidential Information to any third party in any way without Tianjin Happy Life Tech Co.,Ltd.’s prior written consent.

5/F, China Life Tower No. 16 Chaowai St Chaoyang District Beijing, 100020 ChinaAt Truven Health Analytics™, our purpose is to make healthcare better — lower costs, improved quality, better results. Simple words. Yet remarkably complex concepts. But that's not stopping us. Or our customers. Every day, we get to work with smart, passionate professionals, from every facet of the industry, as they manage change and implement strategies that will achieve exactly those outcomes. Our customers are healthcare payers and providers. In both the private and public sectors. They're researchers and suppliers. Regulators. Movers and shakers in each piece and part of the healthcare world. With this broad view of healthcare, we're able to see when new challenges are just beginning to emerge. And that's when we begin working on new solutions. Data. We're driven by it. Known for our exacting collection and secure management of data, we've worked with clinical evidence, claims, clinical, and other healthcare data for more than 40 years. We know the challenges to watch for, what to do about them — and how to recognize new ones. Like finding new ways to measure risk for providers who take on more of it, and payers who contract for it. Or integrating data to deliver the solutions today's converging healthcare interests demand. Analytics. Because data alone is just numbers and letters. The need for reliable insights from data demands proven analytics. Our methodologies and algorithms are uniformly trusted across the industry to deliver critical information that leads to confident decisions. Coupled with flexible reporting, integration, and consulting services, our sophisticated analytics enable our customers to make their part of healthcare better, faster. Domain expertise. We have it. We really have walked in our customers' shoes. We've worked in their environments. That level of understanding, plus our leading data management capabilities and advanced analytics, are why our customers turn to us as their partner to deliver quality, reduce costs, and yield greater value in healthcare.

30 Shuangqing Rd Haidian Qu, Beijing Shi, 100084 ChinaTsinghua University was established in 1911, originally under the name “Tsinghua Xuetang”. The school was renamed "Tsinghua School" in 1912. The university section was founded in 1925. The name “National Tsinghua University” was adopted in 1928. The faculty greatly valued the interaction between Chinese and Western cultures, the sciences and humanities, the ancient and modern. Tsinghua scholars Wang Guowei, Liang Qichao, Chen Yinque and Zhao Yuanren, renowned as the "Four Tutors" in the Institute of Chinese Classics, advocated this belief and had a profound impact on Tsinghua's later development. Tsinghua University was forced to move to Kunming and join with Peking University and Nankai University to form the Southwest Associated University due to the Resistance War against the Japanese Invasion in 1937. In 1946 The University was moved back to its original location in Beijing after the war. After the founding of the People's Republic of China, the University was molded into a polytechnic institute focusing on engineering in the nationwide restructuring of universities and colleges undertaken in 1952. In November 1952, Mr. Jiang Nanxiang became the President of the University. He made significant contributions in leading Tsinghua to become the national center for training engineers and scientists with both professional proficiency and personal integrity. Since China opened up to the world in 1978, Tsinghua University has developed at a breathtaking pace into a comprehensive research university. At present, the university has 14 schools and 56 departments with faculties in science, engineering, humanities, law, medicine, history, philosophy, economics, management, education and art. The University has now over 25,900 students, including 13,100 undergraduates and 12,800 graduate students. As one of China’s most renowned universities, Tsinghua has become an important institution for fostering talent and scientific research. The educational philosophy of Tsinghua is to "train students with integrity." Among over 120,000 students who have graduated from Tsinghua since its founding are many outstanding scholars, eminent entrepreneurs and great statesmen remembered and respected by their fellow Chinese citizens. With the motto of “Self-Discipline and Social Commitment” and the spirit of “Actions Speak Louder than Words”, Tsinghua University is dedicated to the well-being of Chinese society and to world development.

Shuang Qing Lu, , Beijing Shi 100084, CNTsinghua University was established in 1911, originally under the name “Tsinghua Xuetang”. The school was renamed "Tsinghua School" in 1912. The university section was founded in 1925. The name “National Tsinghua University” was adopted in 1928. The faculty greatly valued the interaction between Chinese and Western cultures, the sciences and humanities, the ancient and modern. Tsinghua scholars Wang Guowei, Liang Qichao, Chen Yinque and Zhao Yuanren, renowned as the "Four Tutors" in the Institute of Chinese Classics, advocated this belief and had a profound impact on Tsinghua's later development. Tsinghua University was forced to move to Kunming and join with Peking University and Nankai University to form the Southwest Associated University due to the Resistance War against the Japanese Invasion in 1937. In 1946 The University was moved back to its original location in Beijing after the war. After the founding of the People's Republic of China, the University was molded into a polytechnic institute focusing on engineering in the nationwide restructuring of universities and colleges undertaken in 1952. In November 1952, Mr. Jiang Nanxiang became the President of the University. He made significant contributions in leading Tsinghua to become the national center for training engineers and scientists with both professional proficiency and personal integrity. Since China opened up to the world in 1978, Tsinghua University has developed at a breathtaking pace into a comprehensive research university. At present, the university has 14 schools and 56 departments with faculties in science, engineering, humanities, law, medicine, history, philosophy, economics, management, education and art. The University has now over 25,900 students, including 13,100 undergraduates and 12,800 graduate students. As one of China’s most renowned universities, Tsinghua has become an important institution for fostering talent and scientific research. The educational philosophy of Tsinghua is to "train students with integrity." Among over 120,000 students who have graduated from Tsinghua since its founding are many outstanding scholars, eminent entrepreneurs and great statesmen remembered and respected by their fellow Chinese citizens. With the motto of “Self-Discipline and Social Commitment” and the spirit of “Actions Speak Louder than Words”, Tsinghua University is dedicated to the well-being of Chinese society and to world development.

33 Science Park Road, Building B, Changping District Beijing Beijing, Beijing, 102206 ChinaUnited-Power Pharma Tech Co., Ltd (UPP) is a bioanalytical focused CRO which provides high-quality pharmacokinetic, pharmacodynamic and immunogenicity evaluations for both biopharmaceutical and new chemical entities (NCE) in support of different stages of drug discovery and development programs. UPP was founded in 2008 with our headquarters in Zhongguancun Life Science Park in Beijing. UPP has four test facilities in China with more than 15000-square-meter floor space to expedite our quality delivery. Thriving for scientific and quality excellence, we have proudly supported PK, PD and immunogenicity evaluation for more than six hundreds of discovery and development programs. We follow ISO/IEC17025 quality standards and the relevant regulatory guidance from NMPA, EMA, FDA and ICH. UPP had been accredited by CHINA NATIONAL ACCREDITATION SERVICE FOR CONFORMITY ASSESSMENT (CNAS) since 2017 for both biomolecule and small molecule bioanalysis. UPP has built strong collaboration with over 400 clients including many global pharmaceutical companies.

33 Science Park Road, Building B, Changping District Beijing, Beijing, 102206 ChinaUnited-Power Pharma Tech Co., Ltd (UPP) is a bioanalytical focused CRO which provides high-quality pharmacokinetic, pharmacodynamic and immunogenicity evaluations for both biopharmaceutical and new chemical entities (NCE) in support of different stages of drug discovery and development programs. UPP was founded in 2008 with our headquarters in Zhongguancun Life Science Park in Beijing. UPP has four test facilities in China with more than 15000-square-meter floor space to expedite our quality delivery. Thriving for scientific and quality excellence, we have proudly supported PK, PD and immunogenicity evaluation for more than six hundreds of discovery and development programs. We follow ISO/IEC17025 quality standards and the relevant regulatory guidance from NMPA, EMA, FDA and ICH. UPP had been accredited by CHINA NATIONAL ACCREDITATION SERVICE FOR CONFORMITY ASSESSMENT (CNAS) since 2017 for both biomolecule and small molecule bioanalysis. UPP has built strong collaboration with over 400 clients including many global pharmaceutical companies.

No.6 Yongchang ZhongLu, BDA Beijing 100176 ChinaVector Gene Technology offers adeno-associated virus (AAV), adenovirus and plasmid-DNA services.

NO.3 Jinzhuang, Si Ji Qing, Haidian District, Beijing, 100089, ChinaVenturepharm Laboratories offers API intermediates, detection, analysis, toxicology, and pharmacokinetic services.

No. 4 Yangshan Rd., Chaoyang district, Beijing, ChinaVital River Laboratories provides commercial production of laboratory animal in China

Room 104, Shidao Soloon Building No. 2 Tong Ji Middle Road Beijing Economic-Technological Development Area Beijing 100176 ChinaWacker offers contract manufacturing, biologic analysis, and quality control/assurance services.

100094 No.2 Yuanmingyuan West Rd. Haidian District, Beijing, ChinaWanger Biotech provides ELISA kits, polyclonal and monoclonal antibody services.

Haidian District, Beijing, China Room 504, Block D Keshi Building, No.28, Shangdi Xinxi Road, Beijing, Beijing, 100000 ChinaWecomput Technology Co., Ltd. provides computional solutions for biomedicine, and is committed to innovating drug discovery by integrating cutting-edge technologies like artificial intelligence, biophysics, high-performance computing, generative biology, et al. Wecomput has created a unique platform for drug molecule generation, design and simulation, including proteins, antibodies, RNAs, and small molecules. In 2021, Wecomput received equity investment from Sequoia Capital China and was selected into the NVIDIA Inception program. So far, Wecomput have collaborated with 300+ customers or partners all over the world, covering many biopharmas, universities, hospitals, and institutes, including Otsuka, NVIDIA, University of California, Karolinska Institutet, CDC, Simcere, Shanghai Pharma, SinoPharm, WuXi AppTec, et al.

601 Yingzhi Dasha,49-3 Suzhoujie of Haidian Dist. Beijing 100080 ChinaXuyue (Beijing) Sci. & Tech., using the non-invasive micro-test technique (NMT), provides ionic and molecular profiling services.

Beijing, ChinaYale Pharmaceutical Research Institute offers drug discovery and design, combinatorial chemistry, organic synthesis, ADME testing, pharmacological models, and toxicity services.

7 Rong Chang Dong Jie Beijing Shi, 100176 ChinaYitai Pharmaceuticals offers bulk drug and intermediate synthesis services.

4th Floor, Fuxing Building, No. 7 Rongchang Donglu Economic Technical Development District Beijing 100176 ChinaYitai Pharmaceuticals offers bulk drug and intermediate synthesis services.

Chao Yang North Road, Chao Yang District, Beijing, ChinaZizhu Pharmaceutical specializes in manufacture of API and ingredients.